Opioid Receptors - Pharmacology
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review | HTML
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction: Trends in Neurosciences
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Development of κ opioid receptor antagonists. | Semantic Scholar
Schematic representation of dynorphin/kappa opioid receptor system... | Download Scientific Diagram
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist | PNAS
κ-opioid receptor - Wikipedia
Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology | PLOS ONE
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Development of κ opioid receptor antagonists. - Abstract - Europe PMC
δ-opioid receptor - wikidoc
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Opioid Receptor | kappa, mu Opioid Receptor
Opioids in cancer: The κ‑opioid receptor (Review)
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Duration of Action of a Broad Range of Selective κ-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation | Molecular Pharmacology
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
